# InvestorNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025

BioAdaptives (OTC Pink: BDPT), a wellness innovator, announced the national rollout of NeuroRush(TM), its next-generation nootropic aimed at enhancing mental clarity, cognitive endurance, and stress adaptability. Following strong results in test markets, the adaptogen-based formula will launch in August/September 2025 in two versions—one with natural caffeine and one caffeine-free. Formulated with clinically studied ingredients like Rhodiola, Ashwagandha, and Bacopa, NeuroRush(TM) supports brain health without the crash of stimulants. The product will be available online and through strategic wellness partners.

 To view the full press release, visit https://ibn.fm/2CwVh

 About BioAdaptives, Inc.

 BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness industry. We are dedicated to developing and marketing nutraceutical and wellness products that harness the power of natural ingredients and cutting-edge science. Our mission is to improve the quality of life for our customers by offering products that support optimal health and vitality.

 For more information, please visit our website at www.bioadaptives.com.

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireAustin, Texaswww.InvestorWire.com512.354.7000 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-bioadaptives-inc-otc-pink-bdpt-prepares-for-national-launch-of-neurorushtm-nootropic-in-late-summer-2025/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/bioadaptives-launches-neurorush-tm-a-revolutionary-nootropic-for-cognitive-enhancement/79ef17bebbbcc20277d090d274c20520) 

 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1m1edmp/bioadaptives_launches_neurorushtm_a_revolutionary/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/257/16/voltg6M5.webp)